International Eczema Council
Founded in late 2014, the International Eczema Council (IEC) brings together scientists and physicians dedicated to improve patient care by promoting research, education, and best practices in treatment for atopic dermatitis in people worldwide.
ISDS 2025 Atopic Dermatitis and Alopecia Areata Nuances of Clinical Trial Design and Recruitment
EADV 2025 Atopic Dermatitis versus Cutaneous Tcell Lymphoma Challenges and Novel Insights PART 2
EADV 2025 Atopic Dermatitis versus Cutaneous Tcell Lymphoma Challenges and Novel Insights PART 1
SID 2025 Practical Applications of Multiomics in Atopic Dermatitis Part 2 10am 12pm
SID 2025 Practical Applications of Multiomics in Atopic Dermatitis Part 1 8am 945am
WCPD 2025 Practical Strategies for Preventing, Treating & Managing AD in Pediatric Populations
AAAAI 2025 Impact of Environmental, Food, and Contact Allergies on AD
AAD 2025 Converging Pathways Atopic Dermatitis and Alopecia Areata
EAACI 2024 | The experience from clinical trials | Alan Irvine MD DSc
EAACI 2024 | The real world data | Marjolein de Bruin-Weller, MD PhD
EAACI 24 Mechanisms & consequences of Jak STAT signaling in the immune system | Ioana Agache MD PhD
IEC Symposium on Chronic Hand Eczema | EADV 2024
IEC/IPC Symposium From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis & Eczema
IEC Symposium on Infections and Immunization in Patients with Atopic Dermatitis | RADLA 2024
Presenter Panel Discussion and Audience Q&A | All Presenters| EAACI 2024
The real world data | Marjolein de Bruin Weller MD PhD | EAACI 2024
The experience from clinical trials | Alan Irvine MD DSc | EAACI 2024
Mechanisms and consequences of Jak STAT signaling in the immune system Ioana Agache MD PhD
Welcome from the IEC & Program Overview Alan Irvine, MD DSc EAACI 2024
IEC Symposium on What's New in Pathogenesis & Mechanisms? Drivers of Disease Part 2 10-12 PM Central
IEC Symposium on What's New in Pathogenesis & Mechanisms? Drivers of Disease Part 1 8-10 AM Central
Cardiovascular Comorbidities
Autoimmune Comorbidities
Psychiatric Comorbidities
Economics and Healthcare in Atopic Dermatitis
Atopic Dermatitis Topical Study Design
PDE-4 Inhibitors
Topical therapies: Tapinarof and beyond
Topical JAK Inhibitors in AD
Mechanisms for Prevention of Atopic Dermatitis using Topical Products